Orange Book product · Generic (ANDA)
CAFFEINE CITRATE
CAFFEINE CITRATE
At a glance
Jan 31, 2008
Approved
Generic (ANDA)
Application
AA
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 31, 2008
18 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CAFFEINE CITRATE
Strength
EQ 30MG BASE/3ML (EQ 10MG BASE/ML)
Dosage form
SOLUTION
Route
ORAL
TE code
AA
Application
ANDA 078002
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CAFFEINE CITRATE
- 1999CAFCITBrand (NDA)
NDA 020793 · HIKMA
- 2019CAFFEINE CITRATEGeneric (ANDA)
ANDA 213202 · MICRO LABS
- 2017CAFFEINE CITRATEGeneric (ANDA)
ANDA 207400 · MICRO LABS
- 2015CAFFEINE CITRATEGeneric (ANDA)
ANDA 205013 · EUGIA PHARMA
- 2012CAFFEINE CITRATEGeneric (ANDA)
ANDA 090827 · SAGENT PHARMS
- 2012CAFFEINE CITRATEGeneric (ANDA)
ANDA 091102 · SAGENT PHARMS
- 2009CAFFEINE CITRATEGeneric (ANDA)
ANDA 090064 · AM REGENT
- 2009CAFFEINE CITRATEGeneric (ANDA)
ANDA 090077 · SUN PHARM
- 2009CAFFEINE CITRATEGeneric (ANDA)
ANDA 090357 · SUN PHARM
- 2007CAFFEINE CITRATEGeneric (ANDA)
ANDA 077997 · FRESENIUS KABI USA
- 2007CAFFEINE CITRATEGeneric (ANDA)
ANDA 077906 · AM REGENT
- 2006CAFFEINE CITRATEGeneric (ANDA)
ANDA 077233 · EXELA PHARMA SCIENCE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
